Vector Science Hires Ex-Outcome Capital Banker to Lead M&A Push
Image
Toronto – October 19, 2026 -- Vector Science and Therapeutics Corp. (TSXV: PAIN) has appointed Angus Jackson, a former investment banker at Outcome Capital, as Managing Director of Corporate Development. He will lead the company's inorganic growth initiatives, including acquisitions, investments and strategic partnerships.
Jackson takes charge of inorganic growth and supports organic expansion
Jackson will lead inorganic growth and assist with organic growth. His remit covers commercial expansion, strategic alliances, business development and selective mergers and acquisitions. He will also work with company leadership to assess opportunities that complement Vector's therapeutic delivery technologies, medical devices and peptide-related offerings.